Stock Price of HCP, Inc. (HCP) Increases 5.05%

HCP, Inc.s in-depth data and chart pattern analysis indicates that the stock price has rallied 12.24% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -14.4% . Looking at the past 52 week period, the stock price is up at 9.16% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of HCP, Inc. has a negative value of -8.78 compared to overall market performance.

HCP, Inc. stock has recorded a 20-day Moving Average of 7.1% and the 50-Day Moving Average is 8.96%.The 200 Day SMA reached 4.45%Based on the Stock Research the Relative Strength Index signal is in over bought territory with a range of 75.94. HCP, Inc. (NYSE:HCP) has climbed 5.05% in the past week and advanced 10.42% in the last 4 weeks. In the past week, the company has outperformed the S&P 500 by 4.34% and the outperformance has advanced to 7.03% for the last 4 weeks period.

HCP, Inc. (NYSE:HCP) : On Friday heightened volatility was witnessed in HCP, Inc. (NYSE:HCP) which led to swings in the share price. The stock opened for trading at $32.04 and hit $32.69 on the upside , eventually ending the session at $32.64, with a gain of 1.59% or 0.51 points. The heightened volatility saw the trading volume jump to 3,834,950 shares. The 52-week high of the share price is $36.50149 and the company has a market cap of $15,281 million. The 52-week low of the share price is at $25.324432 .

Currently the company Insiders own 0.22% of HCP, Inc. shares according to the proxy statements. Institutional Investors own 94.29% of HCP, Inc. shares. Company has reported several Insider transactions to the SEC, on Jan 31, 2017, Thomas Klaritch (Senior Managing Director) sold 16,519 shares at 40.15 per share price.On Sep 8, 2016, Thomas D Kirby (Executive Vice President) sold 3,000 shares at 40.24 per share price.On Sep 1, 2016, Darren A Kowalske (Executive Vice President) sold 2,250 shares at 39.20 per share price.

Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.HCP was Upgraded by Goldman to Buy on Jan 25, 2017. HCP was Resumed by Barclays on Jan 5, 2017 to Equal Weight, Price Target of the shares are set at $32.

HCP Last issued its quarterly earnings results on Feb 13, 2017. The company reported $0.59 EPS for the quarter, beating the analyst consensus estimate by $ 0.02. Analyst had a consensus of $0.57. The company had revenue of $540.00 million for the quarter, compared to analysts expectations of $546.91 million. The companys revenue was up 3.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.80 EPS.

Health Care Property Investors, Inc. is a real estate investment trust. The company invests in health care related real estate located throughout the United States, including long-term care facilities, congregate care and assisted living facilities, acute care and rehabilitation hospitals, medical office buildings, physician group practice clinics and psychiatric facilities.

HCP,

Add Comment